Literature DB >> 28834202

Hypothesis on a relationship between hyperaldosteronism, inflammation, somatic mutations, and autoimmunity.

Decio Armanini1, Alessandra Andrisani2, Gabriella Donà1, Luciana Bordin3, Guido Ambrosini2, Chiara Sabbadin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28834202      PMCID： PMC8030760          DOI： 10.1111/jch.13074

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  24 in total

1.  Association of primary aldosteronism with chronic thyroiditis.

Authors:  Chiara Sabbadin; Caterina Mian; Davide Nacamulli; Gabriella Donà; Fabio Presotto; Corrado Betterle; Marco Boscaro; Luciana Bordin; Decio Armanini
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

2.  Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate.

Authors:  Decio Armanini; Cristina Fiore; Donatella Pellati
Journal:  Hypertension       Date:  2007-08-20       Impact factor: 10.190

Review 3.  An update on novel mechanisms of primary aldosteronism.

Authors:  Maria-Christina Zennaro; Sheerazed Boulkroun; Fabio Fernandes-Rosa
Journal:  J Endocrinol       Date:  2014-11-25       Impact factor: 4.286

4.  Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes.

Authors:  M Wehling; D Armanini; T Strasser; P C Weber
Journal:  Am J Physiol       Date:  1987-04

5.  Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Giulio Clari; Luciana Bordin
Journal:  Expert Opin Pharmacother       Date:  2014-03-11       Impact factor: 3.889

Review 6.  Aldosterone as a modulator of immunity: implications in the organ damage.

Authors:  Andrés A Herrada; Carmen Campino; Cristián A Amador; Luis F Michea; Carlos E Fardella; Alexis M Kalergis
Journal:  J Hypertens       Date:  2011-09       Impact factor: 4.844

7.  AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.

Authors:  Ralf Dechend; Christiane Viedt; Dominik N Müller; Bernhard Ugele; Ralf P Brandes; Gerd Wallukat; Joon-Keun Park; Jurgen Janke; Peter Barta; Jurgen Theuer; Anette Fiebeler; Volker Homuth; Rainer Dietz; Hermann Haller; Jörg Kreuzer; Friedrich C Luft
Journal:  Circulation       Date:  2003-02-24       Impact factor: 29.690

8.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

9.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 10.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240
View more
  9 in total

Review 1.  Common innate pathways to autoimmune disease.

Authors:  David Langan; Noel R Rose; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2020-02-10       Impact factor: 3.969

2.  Hypertension in pregnancy: Role of body mass index, insulin resistance, aldosterone, and calcium homeostasis.

Authors:  Decio Armanini; Alessandra Andrisani; Guido Ambrosini; Gabriella Donà; Luciana Bordin; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-16       Impact factor: 3.738

3.  Relationship between sodium, pentraxin-3 and aldosterone in inflammation and cardiovascular risk.

Authors:  Decio Armanini; Luciana Bordin; Gabriella Donà; Raffaele Pezzani; Alessandra Andrisani; Guido Ambrosini; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-27       Impact factor: 3.738

4.  Uterine fibroids and risk of hypertension: Implication of inflammation and a possible role of the renin-angiotensin-aldosterone system.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Luciana Bordin; Loris Marin; Alessandra Andrisani; Guido Ambrosini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

5.  Relationship between water and salt intake, osmolality, vasopressin, and aldosterone in the regulation of blood pressure.

Authors:  Decio Armanini; Luciana Bordin; Gabriella Dona'; Alessandra Andrisani; Guido Ambrosini; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-19       Impact factor: 3.738

6.  Primary aldosteronism: Involvement of sympathetic system in the persistence of hypertension after surgery.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

7.  Serum sodium on admission affects postoperative in-hospital mortality in acute aortic dissection patients.

Authors:  Pengfei Huang; Hongyan Wang; Dong Ma; Yongbo Zhao; Xiao Liu; Peng Su; Jinjin Zhang; Shuo Ma; Zhe Pan; Juexin Shi; Fangfang Hou; Nana Zhang; Xiaohui Zheng; Nan Liu; Ling Zhang
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

8.  Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role.

Authors:  Chiara Sabbadin; Filippo Ceccato; Eugenio Ragazzi; Marco Boscaro; Corrado Betterle; Decio Armanini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-29       Impact factor: 3.738

9.  Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors.

Authors:  Decio Armanini; Chiara Sabbadin; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-06-16       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.